Compare
Candriam Eq. L Biotechnology C $ LU0108459040
Asset allocation
| Foreign stocks | 98.80% |
| Other | 1.20% |
| Total NAV | 448.81 mln (United States Dollar) |
Update date: 3/31/2026
Currency allocation
| United States Dollar | 93.06% |
| Euro | 2.83% |
| Danish Krone | 2.48% |
| Non definito | 1.20% |
| Swiss Franc | 0.43% |
Update date: 3/31/2026
Geographical allocation
| North America | 85.48% |
| Europe | 13.33% |
| World / Multiple areas | 1.20% |
Update date: 3/31/2026
Sector allocation
| Health Care | 94.66% |
| MATERIALS & COMMODITIES | 1.94% |
| Not Available | 1.20% |
| INDUSTRIALS | 1.18% |
| FINANCIALS | 0.59% |
| Consumer Staples | 0.43% |
Update date: 3/31/2026
Top Ten holdings
| GILEAD SCIENCES INC | 4.69% |
| VERTEX PHARMACEUTICALS INC | 4.34% |
| AMGEN INC | 4.15% |
| REGENERON PHARMACEUTICALS | 3.95% |
| ALNYLAM PHARMACEUTICALS INC | 3.49% |
| INSMED INC | 3.26% |
| BIOGEN INC | 3.23% |
| ROIVANT SCIENCES LTD | 2.68% |
| MADRIGAL PHARMACEUTICALS INC | 2.46% |
| ASCENDIS PHARMA A/S | 2.30% |
Update date: 3/31/2026